Articles
Lexaria Bioscience Making Big Moves in the Lucrative GLP-1 Market
Lexaria turned their attention towards the exploding GLP-1 market - the hottest corner of the pharmaceutical industry, projected to be valued at more than $100 billion annual dollar range by 2030.
CSE Evolves as Member Companies Grow
The Canadian Securities Exchange (CSE) has had a keen awareness of issuer needs since its inception 20 years ago, when a group of experienced stock exchange professionals and members of the trading community got together to provide exchange services for growing Canadian companies.
Behind the scenes at EXCHANGE: Innovation and advanced strategies in the ETF Space
An ETF Experience Conference, held in Miami Beach, Florida, was back again this February and has emerged as a landmark event in the financial industry.
Volatile Markets Spawn New Thinking on Portfolio Construction
Current market trends have challenged many advisors’ long-standing favour for the 60/40 investment mix which allocates 60% of a portfolio to equities and 40% to fixed income assets - with adjustments according to an investor’s time horizon, risk tolerance, and financial goals.
Index Investing: A Timely Solution for Cost-Conscious Investors
With the cost of living still stubbornly high, consumers are being forced to find new ways to get the most for their money. Shouldn’t the same apply to investing? High management fees associated with owning investment products can significantly erode returns and threaten financial goals, and that’s compelling people to step back and reconsider their investment strategies.